Researchers examined the prevalence of co-occurring psychiatric and medical conditions of pregnant individuals hospitalized with and without cannabis use disorder by concomitant substance use disorders.
There is an association between sleep onset timing and the risk of developing cardiovascular disease.
Investigators conducted a randomized clinical trial to evaluate the impact of an online, single-day cognitive behavioral therapy program on women with postpartum depression.
Vision impairment is associated with increased odds of future depressive symptoms among midlife women.
A history of migraine prior to pregnancy is associated with anxiety and with mixed depression and anxiety in mid-pregnancy and late pregnancy, respectively.
Researchers analyzed gestational exposure to antipsychotics and risk of preterm birth, neurodevelopmental disorders, and being small for gestational age.
Depression during pregnancy is associated with increased odds of preterm birth and low birth weight, with stronger associations seen for African Americans.
Antidepressant and antipsychotic prescribing is common prior to diagnosis of type 2 diabetes.
Rates of biochemically verified prenatal cannabis use increased significantly among pregnant women in Northern California during the COVID-19 pandemic.
Pregnant women with schizophrenia experience more pregnancy, delivery, and neonatal complications versus women without severe mental disorders.
